Concentra Group Holdings Parent, Inc.
$31.91▲ 3.70%(+$1.14)
TickerSpark Score
76/100
▌ Solid
73
Valuation
75
Profitability
70
Growth
64
Health
100
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CON research report →
52-Week Range100% of range
Low
$18.55
Current
$31.91
High
$31.93
Company Overviewwww.concentra.com
About the company
Concentra Group Holdings Parent, Inc. is a U. S.
- CEO
- William Keith Newton
- IPO
- 2010
- Employees
- 8,758
- HQ
- Mechanicsburg, PA, US
Price Chart
+54.53% · this period
Valuation
- Market Cap
- $4.08B
- P/E
- 22.96
- P/S
- 1.83
- P/B
- 9.52
- EV/EBITDA
- 14.27
- Div Yield
- 0.78%
Profitability
- Gross Margin
- 27.79%
- Op Margin
- 94.26%
- Net Margin
- 7.97%
- ROE
- 46.05%
- ROIC
- 60.75%
Growth & Income
- Revenue
- $2.16B · 13.85%
- Net Income
- $172.80M · 3.76%
- EPS
- $1.39 · 6.92%
- Op Income
- $2.09B
- FCF YoY
- -6.32%
Performance & Tape
- 52W High
- $31.93
- 52W Low
- $18.55
- 50D MA
- $25.92
- 200D MA
- $22.35
- Beta
- 0.65
- Avg Volume
- 883.83K
Get TickerSpark's AI analysis on CON
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Form 4 · Filings
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 1, 26 | ORTENZIO ROBERT A | sell | 130,000 |
| May 8, 26 | ORTENZIO ROBERT A | sell | 130,000 |
| Dec 17, 25 | Newton William Keith | other | 89,081 |
| Dec 17, 25 | Newton William Keith | other | 89,081 |
| Nov 26, 25 | Ryan Timothy F. | other | 5,903 |
| Nov 26, 25 | Rhine Michael D. | other | 3,935 |
| Nov 26, 25 | Nelson Su Zan | other | 5,903 |
| Nov 26, 25 | McAndrew Douglas R. | other | 5,903 |
| Nov 26, 25 | Kosuth Michael A. | other | 6,449 |
| Nov 26, 25 | Kendall Danielle | other | 3,935 |
Coverage · CON
Our CON coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on CON yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CON report →Internal Compare
Similar companies
Peers in the same neighborhood.
HAE▲0.29%
Haemonetics Corporation
$75.07
XRAY▲5.05%
DENTSPLY SIRONA Inc.
$11.65
BHC▲2.73%
Bausch Health Companies Inc.
$4.90
CPRX▲0.03%
Catalyst Pharmaceuticals, Inc.
$31.45
PINC▲0.32%
Premier, Inc.
$28.26
ITGR▲0.60%
Integer Holdings Corporation
$95.14
HCM▲6.12%
HUTCHMED (China) Limited
$11.44
BEAM▲3.91%
Beam Therapeutics Inc.
$34.79